Bentham Science: How We Avoid Predatory Publishing

 

Bentham Science Publishers publishes over 140 scholarly journals (Subscription based and Open Access) related to various subject areas of science, technology and medicine. The journals are indexed, recognized and associated with reputable scientific agencies, directories and other entities.

Each article submitted to Bentham Science journals (Subscription and Open Access) is rigorously peer-reviewed. You can read more about our peer review process here. Bentham’s publications are also part of COPE, an organization that aims to define best practice in the ethics of scholarly publishing and to assist authors, editors and publishers to achieve the defined standards. We have several notable journals included in the Journal Citation Reports of Clarivate Analytics with Impact Factor rankings.

The article published in Springer, Medicine, Health Care and Philosophy, that discusses predatory publishing, highlighted a link from a controversial list by Jeffery Beall which has been taken down due to its controversial nature. However, even if one considers his list, he had included publishers such as Biomed Central (part of the Springer-Nature group), Frontier Science etc., all of which are thoroughly respected and reputable publishers. This does not mean that those 2 publishers are predatory, and the same rule applies here. Bentham Science has promptly and clearly addressed all allegations in the past, of any predatory practices, and has duly satisfied its stakeholders and maintained their trust and association. Repetition of such claims is false and misleading. To read the full blog, please visit: https://bit.ly/2HkozFU

PR.png

Press Release | Computational advances in the label-free quantification of cancer proteomics data

 

In recent years, proteomics research has become a popular method for characterizing the functional proteins driving the transformation of malignancy, tracing the large-scale protein alterations induced by anti-cancer drug, as well as discovering the innovative targets and first-in-class drugs for oncologic disorders. Proteomics became popular due to its ability to provide quantitative and dynamic information on tumor genesis and development by directly profiling protein expression. Label-free Quantification (LFQ) is an important method for quantifying protein expression in cancer proteomics. However, the main challenge in using this method for discovering anti-cancer targets and drugs is the low precision, poor reproducibility, and inaccuracy of the LFQ of proteomics data.

 

cancer-proteomics-13-638

 

Read full press release to find out more at: https://www.eurekalert.org/pub_releases/2018-12/bsp-cai122718.php

eBook | A Blueprint for the Hard Problem of Consciousness

Why we need a blueprint for consciousness

The enigma of how consciousness rises from biological phenomena has perplexed scientists, leading some of the greatest minds, including Nobel Laureates Leon Cooper, Francis Crick, Gerald Edelman, Eric Kandel, and Charles Sherrington, to conclude that answering this question is one of the greatest challenges in science. As Shallice [1] concludes, “The problem of consciousness occupies an analogous position for cognitive psychology as the problem of language behavior does for behaviorism, namely, an unsolved anomaly within the domain of the approach”.

Similarly, Chalmers [2] states, “We know consciousness far more intimately than we know the rest of the world, but we understand the rest of the world far better than we understand consciousness”. The puzzle of “consciousness-and-the-brain,” or of the “mind-body” problem, is often ranked as one of the top two unanswered scientific questions [3].

When speaking about consciousness, we are referring to its most basic form, the kind falling under the rubrics of ‘subjective experience,’ ‘qualia,’ ‘sentience,’ ‘basic awareness,’ and ‘phenomenal state.’ This basic form of consciousness has been best defined by Nagel [4], who claimed that an organism has basic consciousness if there is something it is like to be that organism—something it is like, for example, to be human and experience pain, love, or breathlessness. Similarly, Block [5] claimed, “the phenomenally conscious aspect of a state is what it is like to be in that state”. Read out the full version here.

 

Sample File-7665 (1)-1.jpg

 

By

Paulo Jacomo Negro

Become a Reviewer | Current Alzheimer Research (CAR)

 

Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer’s disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive ‘bird’s-eye view’ of the current state of Alzheimer’s research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

 

Abstracted and Indexed in:

  • Science Citation Index-Expanded
  • Journal Citation Reports/Science Edition
  • InCites
  • Neuroscience Citation Index
  • Current Contents® – Life Sciences
  • Current Contents® – Clinical Medicine
  • BIOSIS
  • BIOSIS Previews
  • BIOSIS Reviews Reports and Meetings
  • MEDLINE/PubMed/Index Medicus
  • Scopus
  • EMBASE
  • Chemical Abstracts Service/SciFinder
  • PsycINFO
  • ProQuest
  • ChemWeb
  • Google Scholar
  • BIOBASE
  • EMNursing
  • EMCare
  • Alzforum
  • MediaFinder®-Standard Periodical Directory
  • Genamics JournalSeek
  • PubsHub
  • Index Copernicus
  • J-Gate
  • CNKI Scholar
  • Suweco CZ
  • TOC Premier
  • EBSCO
  • British Library
  • Ulrich’s Periodicals Directory
  • JournalTOCs

 

The Journal is interested in appointing active Reviewers on the Journal’s Board. If you are working in the mentioned field of the journal and are interested in becoming a Reviewer, send us your CV at the below mentioned email. If, however, the scope of the journal is not directly related to your field of interest then please feel free to recommend suitable colleagues for the Reviewers of the journal and, if possible, send us their CV mentioning the field of interest.

 

Please submit the CV at your earliest convenience at hermain@benthamscience.netand CC faizan@benthamscience.net, mentioning in the subject line your field of interest. The responsibilities of Reviewers will be discussed in detail further once the CV is received.

 

reviewer-banner-

Become an Editorial Board Member (EBM) | Current Alzheimer Research (CAR)

 

Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer’s disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive ‘bird’s-eye view’ of the current state of Alzheimer’s research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

 

Abstracted and Indexed in:

  • Science Citation Index-Expanded
  • Journal Citation Reports/Science Edition
  • InCites
  • Neuroscience Citation Index
  • Current Contents® – Life Sciences
  • Current Contents® – Clinical Medicine
  • BIOSIS
  • BIOSIS Previews
  • BIOSIS Reviews Reports and Meetings
  • MEDLINE/PubMed/Index Medicus
  • Scopus
  • EMBASE
  • Chemical Abstracts Service/SciFinder
  • PsycINFO
  • ProQuest
  • ChemWeb
  • Google Scholar
  • BIOBASE
  • EMNursing
  • EMCare
  • Alzforum
  • MediaFinder®-Standard Periodical Directory
  • Genamics JournalSeek
  • PubsHub
  • Index Copernicus
  • J-Gate
  • CNKI Scholar
  • Suweco CZ
  • TOC Premier
  • EBSCO
  • British Library
  • Ulrich’s Periodicals Directory
  • JournalTOCs

 

The Journal is interested in appointing active Editorial Board Members on the Journal’s Board. If you are working in the mentioned field of the journal and are interested in becoming an Editorial Board Member, please send us your CV and a list of publications to the email mentioned below. If, however, the scope of the journal is not directly related to your field of interest then please feel free to recommend suitable colleagues for the Editorial Board membership of the journal and, if possible, send us their CV along with their list of publications.

 

Please submit the CV at your earliest convenience at hermain@benthamscience.netand CC faizan@benthamscience.net, mentioning in the subject line your field of interest. The responsibilities of Editorial Board Members will be discussed in detail further once the CV is received.

 

banner

Wishing you a very Happy Birthday | Dr. Giuseppe Buonocore

 

balloon birthday background 5

 

Dr. Giuseppe Buonocore

Editor in Chief: Current Pediatric Reviews

Department of Molecular and Developmental Medicine
University of Siena
Siena
Italy

Wishing you a very Happy Birthday | Dr. Francis J. Castellino

 

Dr  Francis J Castellino

 

Francis J. Castellino

Editor in Chief: Current Drug Targets

 

Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Become a Reviewer | Current Pharmaceutical Design

 

Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Abstracted and Indexed in:

  • Science Citation Index Expanded (SciSearch®)
  • Science Citation Index®
  • Journal Citation Reports/Science Edition
  • InCites
  • Biochemistry & Biophysics Citation Index®
  • Current Contents® – Life Sciences
  • Medical Documentation Service®
  • Research Alert®
  • Index to Scientific Reviews®
  • Custom Information Services®
  • BIOSIS
  • BIOSIS Previews
  • BIOSIS Reviews Reports and Meetings
  • MEDLINE/PubMed/Index Medicus
  • Scopus
  • EMBASE/Excerpta Medica
  • Chemical Abstracts Service/SciFinder
  • Cambridge Scientific Abstracts (CSA)/ProQuest
  • ChemWeb
  • Google Scholar
  • PubsHub
  • Index Copernicus
  • MediaFinder®-Standard Periodical Directory
  • Genamics JournalSeek
  • J-Gate
  • CNKI Scholar
  • Suweco CZ
  • TOC Premier
  • EBSCO
  • Ulrich’s Periodicals Directory
  • JournalTOCs

The Journal is interested in appointing active Reviewers on the Journal’s Board. If you are working in the mentioned field of the journal and are interested in becoming a Reviewer, send us your CV at the below mentioned email. If, however, the scope of the journal is not directly related to your field of interest then please feel free to recommend suitable colleagues for the Reviewers of the journal and, if possible, send us their CV mentioning the field of interest.

Please submit the CV at your earliest convenience at hermain@benthamscience.netand CC faizan@benthamscience.net. The responsibilities of the Reviewer will be discussed in details further after this stage.

reviewer-banner-

Become an Editorial Board Member (EBM) | Current Pharmaceutical Design

 

Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Abstracted and Indexed in:

  • Science Citation Index Expanded (SciSearch®)
  • Science Citation Index®
  • Journal Citation Reports/Science Edition
  • InCites
  • Biochemistry & Biophysics Citation Index®
  • Current Contents® – Life Sciences
  • Medical Documentation Service®
  • Research Alert®
  • Index to Scientific Reviews®
  • Custom Information Services®
  • BIOSIS
  • BIOSIS Previews
  • BIOSIS Reviews Reports and Meetings
  • MEDLINE/PubMed/Index Medicus
  • Scopus
  • EMBASE/Excerpta Medica
  • Chemical Abstracts Service/SciFinder
  • Cambridge Scientific Abstracts (CSA)/ProQuest
  • ChemWeb
  • Google Scholar
  • PubsHub
  • Index Copernicus
  • MediaFinder®-Standard Periodical Directory
  • Genamics JournalSeek
  • J-Gate
  • CNKI Scholar
  • Suweco CZ
  • TOC Premier
  • EBSCO
  • Ulrich’s Periodicals Directory
  • JournalTOCs

The Journal is interested in appointing active Editorial Board Members on the Journal’s Board. If you are working in the mentioned field of the journal and are interested in becoming an Editorial Board Member, please send us your CV and a list of publications. If, however, the scope of the journal is not directly related to your field of interest then please feel free to recommend suitable colleagues for the Editorial Board membership of the journal and, if possible, send us their CV along with their list of publications.

Please submit the CV at your earliest convenience at hermain@benthamscience.net and CC faizan@benthamscience.net, mentioning in the subject line, the field of interest. The responsibilities of Editorial Board Members will be discussed in details further after this stage.

 

banner

 

Bentham Science Free Trial in GTCOM | Free Trial ends on April 4, 2019

 

Global Tone Communication Technology Co., Ltd. develops online to offline language service solutions for users of Internet/mobile Internet, language big data, and cloud computing technologies. The company offers YeeCloud, an integrated service ecosystem based on cloud computing and language big data, which provides smart language services that include translation, interpretation, localization, technical writing, language big data analysis, and processing services for Internet users, commercial clients, professional translators, and language services providers; and Yeekit, an open translation toolkit and resources sharing platform based on YeeCloud. It also provides Findyee, a mobile ecommerce solution of the YeeCloud, which enable language tutors, translators, clients, and language service providers to access platform services, including demand publishing, trading and payment, instant messaging, real-time location based services, and project progress tracking; YeeTone, a multilingual instant communication tool; YeeCaption, a multimedia-aided screen translation tool; Yeecall, a cloud-based multilingual call center platform; JoveBird, an intelligent financial investment engine that offers financial investment solutions powered by big data and artificial intelligence; and learning services. The company is headquartered in Beijing, China. Global Tone Communication Technology Co., Ltd. operates as a subsidiary of China Translation and Publishing Corp.

 

free-trial2

%d bloggers like this: